Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Thioredoxin participates in a cell death pathway induced by interferon and retinoid combination

An Erratum to this article was published on 19 October 2001

Abstract

Interferons (IFNs) and retinoids are potent tumor growth suppressors. We have shown earlier that the IFN-β and all-trans retinoic acid combination, but not the single agents, induces death in several tumor cell lines. Employing a genetic approach we have recently identified several Genes associated with Retinoid-IFN induced Mortality (GRIM) that mediate the cell death effect of IFN/RA combination. One of the GRIMs, GRIM-12, was identical to human thioredoxin reductase (TR), an enzyme that controls intracellular redox state. To define the participants of TR mediated death pathway we have examined the role of thioredoxin (Trx), its downstream substrate, and its influence on IFN/RA-induced death regulation. Inhibition of the thioredoxin expression by antisense RNA suppressed cell death. Similarly, a mutant Trx1 lacking the critical cysteine residues blocked cell death. In contrast, overexpression of wildtype thioredoxin augmented cell death. This effect of Trx1 was in part due to its ability to augment cell death via caspase-8. The redox inactive Trx1 mutant inhibits the cell death induced by caspase-8 but not caspase-3. These studies identify a novel mechanism of cell death regulation by IFN/RA combination involving redox enzymes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

Abbreviations

FLIP:

FLICE-inhibitory protein

GRIM:

Genes associated with Retinoid-IFN induced mortality

IFN:

Interferon

JAK:

Janus tyrosine kinase

RA:

all trans retinoic acid

SRB:

Sulforhodamine B

STAT:

Signal transducing activator of transcription

TR:

thioredoxin reductase

Trx:

thioredoxin

References

  • Alnemri ES, Fernandes-Alnemri T, Litwack G . 1995 J. Biol. Chem. 270: 4312–4317

  • Arner ES, Holmgren A . 2000 Eur. J. Biochem. 267: 6102–6109

  • Balachandran S, Kim CN, Yeh WC, Mak TW, Bhalla K, Barber GN . 1998 EMBO J. 17: 6888–6902

  • Berlett BS, Stadtman ER . 1997 J. Biol. Chem. 272: 20313–20316

  • Cao L, Yao Y, Lee V, Kiani C, Spaner D, Lin Z, Zhang Y, Adams ME, Yang BB . 2000 J. Cell. Biochem. 77: 569–583

  • Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC . 1998 Science 282: 1318–1321

  • Casso D, Beach D . 1996 Mol. Gen. Genet. 252: 518–529

  • Chelbi-Alix MK, Quignon F, Pelicano L, Koken MH, de The H . 1998 J. Virol. 72: 1043–1051

  • Chin YE, Kitagawa M, Kuida K, Flavell RA, Fu XY . 1997 Mol. Cell. Biol. 17: 5328–5337

  • Choubey D, Li SJ, Datta B, Gutterman JU, Lengyel P . 1996 EMBO J. 15: 5668–5678

  • Darnell Jr JE, Kerr IM, Stark GR . 1994 Science 264: 1415–1421

  • Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME . 1997 Cell 91: 231–241

  • Deiss LP, Kimchi A . 1991 Science 252: 117–120

  • Der SD, Yang YL, Weissmann C, Williams BR . 1997 Proc. Natl. Acad. Sci. USA 94: 3279–3283

  • Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC . 1992 Cell 69: 119–128

  • Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin Jr WG, Livingston DM, Orkin SH, Greenberg ME . 1996 Cell 85: 549–561

  • Gaboli M, Gandini D, Delva L, Wang ZG, Pandolfi PP . 1998 Leuk. Lymphoma 30: 11–22

  • Gallegos A, Gasdaska JR, Taylor CW, Paine-Murrieta GD, Goodman D, Gasdaska PY, Berggren M, Briehl MM, Powis G . 1996 Cancer Res. 56: 5765–5770

  • Gianni M, Terao M, Fortino I, LiCalzi M, Viggiano V, Barbui T, Rambaldi A, Garattini E . 1997 Blood 89: 1001–1012

  • Glass CK, Rose DW, Rosenfeld MG . 1997 Curr. Opin. Cell. Biol. 9: 222–232

  • Gongora C, David G, Pintard L, Tissot C, Hua TD, Dejean A, Mechti N . 1997 J. Biol. Chem. 272: 19457–19463

  • Green DR, Reed JC . 1998 Science 281: 1309–1311

  • Gross A, McDonnell JM, Korsmeyer SJ . 1999 Genes. Dev. 13: 1899–1911

  • Gutterman JU . 1994 Proc. Natl. Acad. Sci. USA 91: 1198–1205

  • Harada H, Becknell B, Wilm M, Mann M, Huang LJ, Taylor SS, Scott JD, Korsmeyer SJ . 1999 Mol. Cell. 3: 413–422

  • Hartman H, Wu M, Buchanan BB, Gerhart JC . 1993 Proc. Natl. Acad. Sci. USA 90: 2271–2275

  • Hermeking H, Eick D . 1994 Science 265: 2091–2093

  • Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, Yodoi J . 1997 Proc. Natl. Acad. Sci. USA 94: 3633–3638

  • Hofmann ER, Boyanapalli M, Lindner DJ, Weihua X, Hassel BA, Jagus R, Gutierrez PL, Kalvakolanu DV . 1998 Mol. Cell. Biol. 18: 6493–6504

  • Holmgren A, Bjornstedt M . 1995 Methods Enzymol. 252: 199–208

  • Holtschke T, Lohler J, Kanno Y, Fehr T, Giese N, Rosenbauer F, Lou J, Knobeloch KP, Gabriele L, Waring J, Bachmann MF, Zinkernagel RM, Morse HC, Ozato K, Horak I . 1996 Cell 87: 307–317

  • Janicke RU, Sprengart ML, Wati MR, Porter AG . 1998 J. Biol. Chem. 273: 9357–9360

  • Kalvakolanu DV . 2000 Histol. Histopathol. 15: 523–537

  • Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD . 1998 Proc. Natl. Acad. Sci. USA 95: 7556–7561

  • Kennedy SG, Kandel ES, Cross TK, Hay N . 1999 Mol. Cell. Biol. 19: 5800–5810

  • Kolla V, Weihua X, Kalvakolanu DV . 1997 J. Biol. Chem. 272: 9742–9748

  • Kurooka H, Kato K, Minoguchi S, Takahashi Y, Ikeda J, Habu S, Osawa N, Buchberg AM, Moriwaki K, Shisa H, Honjo T . 1997 Genomics 39: 331–339

  • Kuwata T, Wang IM, Tamura T, Ponnamperuma RM, Levine R, Holmes KL, Morse HC, De Luca LM, Ozato K . 2000 Blood 95: 3349–3356

  • Lee HY, Dohi DF, Kim YH, Walsh GL, Consoli U, Andreeff M, Dawson MI, Hong WK, Kurie JM . 1998a J. Clin. Invest. 101: 1012–1019

  • Lee KK, Murakawa M, Takahashi S, Tsubuki S, Kawashima S, Sakamaki K, Yonehara S . 1998b J. Biol. Chem. 273: 19160–19166

  • Lee SR, Kim JR, Kwon KS, Yoon HW, Levine RL, Ginsburg A, Rhee SG . 1999 J. Biol. Chem. 274: 4722–4734

  • Levy-Strumpf N, Kimchi A . 1998 Oncogene 17: 3331–3340

  • Li H, Kolluri SK, Gu J, Dawson MI, Cao X, Hobbs PD, Lin B, Chen G, Lu J, Lin F, Xie Z, Fontana JA, Reed JC, Zhang X . 2000 Science 289: 1159–1164

  • Lindner DJ, Borden EC, Kalvakolanu DV . 1997 Clin. Cancer Res. 3: 931–937

  • Lindner DJ, Hofmann ER, Karra S, Kalvakolanu DV . 2000 Biochim. Biophys. Acta. 1496: 196–206

  • Lipton SA . 1999 Cell. Death. Differ. 6: 943–951

  • Liu H, Nishitoh H, Ichijo H, Kyriakis JM . 2000 Mol. Cell. Biol. 20: 2198–2208

  • Liu Y, Lee MO, Wang HG, Li Y, Hashimoto Y, Klaus M, Reed JC, Zhang X . 1996 Mol. Cell. Biol. 16: 1138–1149

  • Lotan R . 1996 FASEB J. 10: 1031–1039

  • Love JM, Gudas LJ . 1994 Curr. Opin. Cell. Biol. 6: 825–831

  • Mangelsdorf DJ, Evans RM . 1995 Cell 83: 841–850

  • Matikainen S, Ronni T, Lehtonen A, Sareneva T, Melen K, Nordling S, Levy DE, Julkunen I . 1997 Cell. Growth. Differ. 8: 687–698

  • Matsui M, Oshima M, Oshima H, Takaku K, Maruyama T, Yodoi J, Taketo MM . 1996 Dev. Biol. 178: 179–185

  • Mohr S, Zech B, Lapetina EG, Brune B . 1997 Biochem. Biophys. Res. Commun. 238: 387–391

  • Moore DM, Kalvakolanu DV, Lippman SM, Kavanagh JJ, Hong WK, Borden EC, Paredes-Espinoza M, Krakoff IH . 1994 Semin. Hematol. 31: 31–37

  • Muller EG . 1991 J. Biol. Chem. 266: 9194–9202

  • Nakamura H, Nakamura K, Yodoi J . 1997 Annu. Rev. Immunol. 15: 351–369

  • Nason-Burchenal K, Gandini D, Botto M, Allopenna J, Seale JR, Cross NC, Goldman JM, Dmitrovsky E, Pandolfi PP . 1996 Blood 88: 3926–3936

  • Pearson GD, Merrill GF . 1998 J. Biol. Chem. 273: 5431–5434

  • Pelicano L, Li F, Schindler C, Chelbi-Alix MK . 1997 Oncogene 15: 2349–2359

  • Pellicena-Palle A, Stitzinger SM, Salz HK . 1997 Mech. Dev. 62: 61–65

  • Piedrafita FJ, Pfahl M . 1997 Mol. Cell. Biol. 17: 6348–6358

  • Pierce AM, Schneider-Broussard R, Gimenez-Conti IB, Russell JL, Conti CJ, Johnson DG . 1999 Mol. Cell. Biol. 19: 6408–6414

  • Pierce RH, Campbell JS, Stephenson AB, Franklin CC, Chaisson M, Poot M, Kavanagh TJ, Rabinovitch PS, Fausto N . 2000 Am. J. Pathol. 157: 221–236

  • Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B . 1997 Nature 389: 300–305

  • Raveh T, Hovanessian AG, Meurs EF, Sonenberg N, Kimchi A . 1996 J. Biol. Chem. 271: 25479–25484

  • Resnitzky D, Tiefenbrun N, Berissi H, Kimchi A . 1992 Proc. Natl. Acad. Sci. USA 89: 402–406

  • Rubartelli A, Bonifaci N, Sitia R . 1995 Cancer Res. 55: 675–680

  • Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H . 1998 EMBO J. 17: 2596–2606

  • Salz HK, Flickinger TW, Mittendorf E, Pellicena-Palle A, Petschek JP, Albrecht EB . 1994 Genetics 136: 1075–1086

  • Sen CK, Sashwati R, Packer L . 1999 Cell. Death. Differ. 6: 481–491

  • Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR . 1990 J. Natl. Cancer Inst. 82: 1107–1112

  • Spyrou G, Enmark E, Miranda-Vizuete A, Gustafsson J . 1997 J. Biol. Chem. 272: 2936–2941

  • Sun QA, Wu Y, Zappacosta F, Jeang KT, Lee BJ, Hatfield DL, Gladyshev VN . 1999 J. Biol. Chem. 274: 24522–24530

  • Sun SY, Yue P, Mao L, Dawson MI, Shroot B, Lamph WW, Heyman RA, Chandraratna RA, Shudo K, Hong WK, Lotan R . 2000 Clin. Cancer Res. 6: 1563–1573

  • Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, Yodoi J . 1989 EMBO J. 8: 757–764

  • Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J . 1997 Nature 386: 517–521

  • Tiefenbrun N, Melamed D, Levy N, Resnitzky D, Hoffman I, Reed SI, Kimchi A . 1996 Mol. Cell. Biol. 16: 3934–3944

  • Ueda S, Nakamura H, Masutani H, Sasada T, Yonehara S, Takabayashi A, Yamaoka Y, Yodoi J . 1998 J. Immunol. 161: 6689–6695

  • Wagner AJ, Kokontis JM, Hay N . 1994 Genes. Dev. 8: 2817–2830

  • Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, Grosveld F, Pandolfi PP . 1998 Science 279: 1547–1551

  • Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF, Taniguchi T . 1993 Science 259: 968–971

  • Zha J, Weiler S, Oh KJ, Wei MC, Korsmeyer SJ . 2000 Science 290: 1761–1765

  • Zhou A, Paranjape J, Brown TL, Nie H, Naik S, Dong B, Chang A, Trapp B, Fairchild R, Colmenares C, Silverman RH . 1997 EMBO J. 16: 6355–6363

Download references

Acknowledgements

These studies are supported by the National Cancer Institute grants CA 78282 and CA 71401 to DV Kalvakolanu and National Institutes of Health grant HL-58122 to SPM Reddy. We thank E Alnemri, and J Tschopp, for providing plasmids used in this study.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ma, X., Karra, S., Lindner, D. et al. Thioredoxin participates in a cell death pathway induced by interferon and retinoid combination. Oncogene 20, 3703–3715 (2001). https://doi.org/10.1038/sj.onc.1204477

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204477

Keywords

This article is cited by

Search

Quick links